# TGF-β1 relieves burn injury induced pain by alleviating inflammation in mouse

**Authors:** Shengfeng Gao, Mengting Wang, Lu Wang, Yasu Jiang, Peng Chen, Li Guo, Lili Ni, Fan Fei, Zhenhua Gong

PMC · DOI: 10.1371/journal.pone.0342029 · PLOS One · 2026-02-05

## TL;DR

This study shows that TGF-β1 reduces pain and inflammation after burn injuries in mice, suggesting it could be a new treatment.

## Contribution

The study demonstrates that TGF-β1 alleviates burn-induced pain by reducing inflammation via the TGF-β1/smad2 pathway.

## Key findings

- TGF-β1 overexpression reduces pro-inflammatory factors like IL-1β, IL-6, and TNF-α.
- TGF-β1 decreases macrophage infiltration and microglia/astrocyte activation in burned skin.
- TGF-β1 promotes smad2 phosphorylation and alleviates mechanical and thermal pain in mice.

## Abstract

Burn injuries are severe traumas characterized by tissue damage and inflammation, and pain is the common symptom of burn patients. Transforming growth factor beta 1 (TGF-β1) is a multifunctional cytokine involved in organ development, immune response, tumor biology and injury repair. This study investigates the effects of TGF-β1 on the burn injury induced pain and explore the underlying mechanisms. A mouse model of second degree burn injury was established, and spinal intrathecal injection with lentivirus was used to knockdown or overexpress TGF-β1. The assessment of mechanical allodynia and thermal hyperalgesia was adapted to evaluate the impact of TGF-β1 on the burn injury induced pain. The expressions of inflammatory factors were measured by using RT-qPCR, while immunofluorescence staining was employed to detect the effects of TGF-β1 on macrophage infiltration in the burned plantar skin. Western blot was used to analyze the effects of TGF-β1 on microglia, astrocytes and signal pathway. RT-qPCR results demonstrated that lentiviruses injection could knockdown or overexpress TGF-β1 in ipsilateral spinal cord, and reduce pro-inflammatory factors (IL-1β, IL-6 and TNF-α) expression and promote anti-inflammatory factor (IL-10) expression. The behavioral assessments revealed that TGF-β1 overexpression alleviated mechanical allodynia and thermal hyperalgesia. Immunofluorescence staining and Western blot revealed that TGF-β1 reduced the macrophage infiltration in the plantar skin, inhibited expressions of marker proteins of microglia and astrocyte, and promoted the phosphorylation of smad2. These findings suggested that TGF-β1 mitigated burn injury induced pain by attenuating inflammatory response via TGF-β1/smad2 pathway. This study provides an experimental and theoretical basis supporting the potential use of TGF-β1 as an anti-inflammatory and analgesic for burn injury.

## Linked entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], IL1B (interleukin 1 beta) [NCBI Gene 3553], IL6 (interleukin 6) [NCBI Gene 3569], TNF (tumor necrosis factor) [NCBI Gene 7124], IL10 (interleukin 10) [NCBI Gene 3586], SMAD2 (SMAD family member 2) [NCBI Gene 4087]
- **Proteins:** TGFB1 (transforming growth factor beta 1), IL1B (interleukin 1 beta), IL6 (interleukin 6), TNF (tumor necrosis factor), IL10 (interleukin 10), SMAD2 (SMAD family member 2)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Tgfbr1 (transforming growth factor, beta receptor I) [NCBI Gene 21812] {aka ALK5, Alk-5, ESK2, TGFR-1, TbetaR-I, TbetaRI}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, IL6ST (interleukin 6 cytokine family signal transducer) [NCBI Gene 3572] {aka CD130, CDW130, GP130, HIES4, HIES4A, HIES4B}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Tgfb2 (transforming growth factor, beta 2) [NCBI Gene 21808] {aka Tgf-beta2, Tgfb-2}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Tgfbr2 (transforming growth factor, beta receptor II) [NCBI Gene 21813] {aka 1110020H15Rik, DNIIR, RIIDN, TBR-II, TbetaR-II, TbetaRII}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, SMAD2 (SMAD family member 2) [NCBI Gene 4087] {aka CHTD8, JV18, JV18-1, LDS6, MADH2, MADR2}, Tgfb3 (transforming growth factor, beta 3) [NCBI Gene 21809] {aka TGF-beta-3, Tgfb-3}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Cd86 (CD86 antigen) [NCBI Gene 12524] {aka B7, B7-2, B7.2, B70, CLS1, Cd28l2}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Arg1 (arginase, liver) [NCBI Gene 11846] {aka AI, Arg-1, PGIF}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Alad (aminolevulinate, delta-, dehydratase) [NCBI Gene 17025] {aka ALADH, Lv}, Smad2 (SMAD family member 2) [NCBI Gene 17126] {aka 7120426M23Rik, Madh2, Madr2, Smad-2, mMad2}, Hc (hemolytic complement) [NCBI Gene 15139] {aka C5, C5a, He, Hfib2}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}
- **Diseases:** paraplegia (MESH:D010264), fibrosis (MESH:D005355), cancer (MESH:D009369), chronic pain (MESH:D059350), Neuropathic pain (MESH:D009437), tissue damage (MESH:D017695), infection (MESH:D007239), autoimmune disorders (MESH:D001327), nerve injury (MESH:D000080902), hypertrophic scar (MESH:D017439), Burn (MESH:D002056), Pain (MESH:D010146), skin damage (MESH:D012871), Peripheral nerve injury (MESH:D059348), inflammation (MESH:D007249), tumorigenesis (MESH:D063646), neuroimmune disorder (MESH:D009358), edema (MESH:D004487), mechanical allodynia (MESH:D006930), trauma (MESH:D014947)
- **Chemicals:** Hematoxylin-Eosin (-), xylene (MESH:D014992), TRIzol (MESH:C411644), SDS (MESH:D012967), DAPI (MESH:C007293), CO2 (MESH:D002245), paraffin (MESH:D010232), xylazine (MESH:D014991), SYBR Green (MESH:C098022), morphine (MESH:D009020), PFA (MESH:C003043), ethanol (MESH:D000431), acepromazine (MESH:D000075), PVDF (MESH:C024865)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), Lv — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_B7Q6)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12875468/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12875468/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12875468/full.md

---
Source: https://tomesphere.com/paper/PMC12875468